Results 191 to 197 of about 13,727 (197)

Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

JAMA - Journal of the American Medical Association, 2019
James L Januzzi, Javed Butler, G Michael Felker   +2 more
exaly  

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study

European Journal of Heart Failure, 2019
Hélène Nougué, Théo Pezel, Mattia Arrigo   +2 more
exaly  

Practical guidance on the use of sacubitril/valsartan for heart failure

Heart Failure Reviews, 2018
Andrew J Sauer, Robert Townsend Cole, Amin Yehya   +2 more
exaly  

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens

European Journal of Heart Failure, 2016
Michele Senni, Rolf Wachter, Manuel Martinez-Selles   +2 more
exaly  

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction

JAMA - Journal of the American Medical Association, 2019
James Fang, Cheryl
exaly  

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure

Circulation: Heart Failure, 2018
Lindsey R Sangaralingham, S Jeson Sangaralingham, Xiaoxi Yao   +2 more
exaly  

Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

Circulation
João Pedro Ferreira, Alvin Chandra, Brian Lee Claggett   +2 more
exaly